 | • レポートコード：GIR-2104Z09818 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、NK（ナチュラルキラー）細胞療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。NK（ナチュラルキラー）細胞療法の種類別市場規模（モガムリズマブ、ロルボツズマブメルタンシン、その他）、用途別市場規模（がん、心血管疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・NK（ナチュラルキラー）細胞療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Chipscreen Biosciences、Affimed NV、Altor BioScience、Innate Pharma、Takeda、Sorrento Therapeutics、NantKwest、Bristol-Myers Squibb、NKT、Henry Ford Health Services ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モガムリズマブ、ロルボツズマブメルタンシン、その他 ・用途別分析2016年-2026年：がん、心血管疾患、その他 ・NK（ナチュラルキラー）細胞療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・NK（ナチュラルキラー）細胞療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・NK（ナチュラルキラー）細胞療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・NK（ナチュラルキラー）細胞療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・NK（ナチュラルキラー）細胞療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Natural Killer (NK) Cell Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Natural Killer (NK) Cell Therapeutics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Natural Killer (NK) Cell Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Natural Killer (NK) Cell Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market segment by Application, can be divided into
Cancer
Cardiovascular Diseases
Others
Market segment by players, this report covers
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Natural Killer (NK) Cell Therapeutics
1.2 Classification of Natural Killer (NK) Cell Therapeutics by Type
1.2.1 Overview: Global Natural Killer (NK) Cell Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type in 2020
1.2.3 Mogamulizumab
1.2.4 Lorvotuzumab Mertansine
1.2.5 Others
1.3 Global Natural Killer (NK) Cell Therapeutics Market by Application
1.3.1 Overview: Global Natural Killer (NK) Cell Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Global Natural Killer (NK) Cell Therapeutics Market Size & Forecast
1.5 Global Natural Killer (NK) Cell Therapeutics Market Size and Forecast by Region
1.5.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Natural Killer (NK) Cell Therapeutics Market Drivers
1.6.2 Natural Killer (NK) Cell Therapeutics Market Restraints
1.6.3 Natural Killer (NK) Cell Therapeutics Trends Analysis
2 Company Profiles
2.1 Chipscreen Biosciences
2.1.1 Chipscreen Biosciences Details
2.1.2 Chipscreen Biosciences Major Business
2.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product and Solutions
2.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Chipscreen Biosciences Recent Developments and Future Plans
2.2 Affimed NV
2.2.1 Affimed NV Details
2.2.2 Affimed NV Major Business
2.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Product and Solutions
2.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Affimed NV Recent Developments and Future Plans
2.3 Altor BioScience
2.3.1 Altor BioScience Details
2.3.2 Altor BioScience Major Business
2.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Product and Solutions
2.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Altor BioScience Recent Developments and Future Plans
2.4 Innate Pharma
2.4.1 Innate Pharma Details
2.4.2 Innate Pharma Major Business
2.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Product and Solutions
2.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Innate Pharma Recent Developments and Future Plans
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Natural Killer (NK) Cell Therapeutics Product and Solutions
2.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Takeda Recent Developments and Future Plans
2.6 Sorrento Therapeutics
2.6.1 Sorrento Therapeutics Details
2.6.2 Sorrento Therapeutics Major Business
2.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product and Solutions
2.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sorrento Therapeutics Recent Developments and Future Plans
2.7 NantKwest
2.7.1 NantKwest Details
2.7.2 NantKwest Major Business
2.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Product and Solutions
2.7.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 NantKwest Recent Developments and Future Plans
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product and Solutions
2.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.9 NKT
2.9.1 NKT Details
2.9.2 NKT Major Business
2.9.3 NKT Natural Killer (NK) Cell Therapeutics Product and Solutions
2.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 NKT Recent Developments and Future Plans
2.10 Henry Ford Health Services
2.10.1 Henry Ford Health Services Details
2.10.2 Henry Ford Health Services Major Business
2.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product and Solutions
2.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Henry Ford Health Services Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Natural Killer (NK) Cell Therapeutics Players Market Share
3.2.2 Top 10 Natural Killer (NK) Cell Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Natural Killer (NK) Cell Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Natural Killer (NK) Cell Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Natural Killer (NK) Cell Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
6.2 North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Country
6.3.1 North America Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
7.2 Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country
7.3.1 Europe Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region
8.3.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Region (2016-2026)
8.3.2 China Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
9.2 South America Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
9.3 South America Natural Killer (NK) Cell Therapeutics Market Size by Country
9.3.1 South America Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country
10.3.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Natural Killer (NK) Cell Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Natural Killer (NK) Cell Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Natural Killer (NK) Cell Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Chipscreen Biosciences Corporate Information, Head Office, and Major Competitors
Table 7. Chipscreen Biosciences Major Business
Table 8. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 9. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Affimed NV Corporate Information, Head Office, and Major Competitors
Table 11. Affimed NV Major Business
Table 12. Affimed NV Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 13. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Altor BioScience Corporate Information, Head Office, and Major Competitors
Table 15. Altor BioScience Major Business
Table 16. Altor BioScience Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 17. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Innate Pharma Corporate Information, Head Office, and Major Competitors
Table 19. Innate Pharma Major Business
Table 20. Innate Pharma Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 21. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Takeda Corporate Information, Head Office, and Major Competitors
Table 23. Takeda Major Business
Table 24. Takeda Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 25. Takeda Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Sorrento Therapeutics Major Business
Table 28. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 29. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. NantKwest Corporate Information, Head Office, and Major Competitors
Table 31. NantKwest Major Business
Table 32. NantKwest Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 33. NantKwest Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 35. Bristol-Myers Squibb Major Business
Table 36. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 37. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. NKT Corporate Information, Head Office, and Major Competitors
Table 39. NKT Major Business
Table 40. NKT Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 41. NKT Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Henry Ford Health Services Corporate Information, Head Office, and Major Competitors
Table 43. Henry Ford Health Services Major Business
Table 44. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 45. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Natural Killer (NK) Cell Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Natural Killer (NK) Cell Therapeutics Players Head Office, Products and Services Provided
Table 50. Natural Killer (NK) Cell Therapeutics Mergers & Acquisitions in the Past Five Years
Table 51. Natural Killer (NK) Cell Therapeutics New Entrants and Expansion Plans
Table 52. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type (2016-2021)
Table 54. Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Type (2021-2026)
Table 55. Global Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021)
Table 56. Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Application (2021-2026)
Table 57. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Natural Killer (NK) Cell Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Natural Killer (NK) Cell Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Natural Killer (NK) Cell Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Natural Killer (NK) Cell Therapeutics Picture
Figure 2. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type in 2020
Figure 3. Mogamulizumab
Figure 4. Lorvotuzumab Mertansine
Figure 5. Others
Figure 6. Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application in 2020
Figure 7. Cancer Picture
Figure 8. Cardiovascular Diseases Picture
Figure 9. Others Picture
Figure 10. Global Natural Killer (NK) Cell Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Natural Killer (NK) Cell Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region (2016-2026)
Figure 13. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region in 2020
Figure 14. North America Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Natural Killer (NK) Cell Therapeutics Market Drivers
Figure 19. Natural Killer (NK) Cell Therapeutics Market Restraints
Figure 20. Natural Killer (NK) Cell Therapeutics Market Trends
Figure 21. Chipscreen Biosciences Recent Developments and Future Plans
Figure 22. Affimed NV Recent Developments and Future Plans
Figure 23. Altor BioScience Recent Developments and Future Plans
Figure 24. Innate Pharma Recent Developments and Future Plans
Figure 25. Takeda Recent Developments and Future Plans
Figure 26. Sorrento Therapeutics Recent Developments and Future Plans
Figure 27. NantKwest Recent Developments and Future Plans
Figure 28. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 29. NKT Recent Developments and Future Plans
Figure 30. Henry Ford Health Services Recent Developments and Future Plans
Figure 32. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players in 2020
Figure 33. Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Natural Killer (NK) Cell Therapeutics Revenue Market Share in 2020
Figure 35. Global Top 10 Players Natural Killer (NK) Cell Therapeutics Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type in 2020
Figure 38. Global Natural Killer (NK) Cell Therapeutics Market Share Forecast by Type (2021-2026)
Figure 39. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application in 2020
Figure 40. Global Natural Killer (NK) Cell Therapeutics Market Share Forecast by Application (2021-2026)
Figure 41. North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 42. North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 43. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. United States Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 48. Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 49. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2016-2026)
Figure 50. Germany Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region (2016-2026)
Figure 58. China Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 65. South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 66. South America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Market Analysis and Insights: Global Merkel Cell Carcinoma Therapeutics Market The global Merkel Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…- 世界の有毛細胞白血病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hairy Cell Leukemia Therapeutics Market The global Hairy Cell Leukemia Therapeutics market size is projected to reach US$ 119.1 million by 2026, from US$ 86 million in 2019, at a CAGR of 4.8% during 2021-2026. With industry-standard accuracy in analysis and high …
- 世界の移行細胞がん治療薬市場規模・現状・予測（2021年-2027年） Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra. Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. Mar…
- 世界の鎌状赤血球貧血治療薬市場規模・現状・予測（2021年-2027年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…